EMD-40819

Single-particle
22.0 Å
EMD-40819 Deposition: 18/05/2023
Map released: 22/05/2024
Last modified: 05/06/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-40819

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, gp41-GH/FP and base from participant 11

EMD-40819

Single-particle
22.0 Å
EMD-40819 Deposition: 18/05/2023
Map released: 22/05/2024
Last modified: 05/06/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, gp41-GH/FP and base from participant 11

Deposition Authors: Karlinsey D, Ozorowski G , Ward AB
HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodies.
Grant Support: